Melanocytic lesion in children and adolescents: an Italian observational study.


Journal

Scientific reports
ISSN: 2045-2322
Titre abrégé: Sci Rep
Pays: England
ID NLM: 101563288

Informations de publication

Date de publication:
25 05 2020
Historique:
received: 07 12 2019
accepted: 21 04 2020
entrez: 27 5 2020
pubmed: 27 5 2020
medline: 2 12 2020
Statut: epublish

Résumé

Malignant melanoma is a rare neoplasm in the pediatric age group. One of the main risks factors is represented by the presence of a high number of melanocytic nevi. Sun exposure in pediatric age represents a predictor of melanocytic nevi number in the adult age and there is a direct correlation between the presence of melanocytic moles in early childhood and the development of many nevi in adults, suggesting that a high number of nevi in childhood should be considered as a predictor of melanoma development during adult life. The predominance of dermoscopic types of melanocytic nevi varies according to the individual's age and depends on endogenous or exogenous signaling, suggesting different pathways of nevogenesis. We evaluated the total amount of melanocytic nevi of pediatric patients and their prevalent dermoscopic pattern. We investigated the reasons for dermatological examination, pointing out the role of older parents' populations in the decision to refer to a dermatological consultant. We performed a prospective observational study on 295 pediatric outpatients consecutively enrolled from July 2018 to July 2019. Descriptive and inferential statistical analyses were performed using logistic and linear regression. 49% of children were characterized by less than 10 nevi, 45% of children by a number of nevi between 10 and 30, whilst 17 patients (5%) had a number of nevi between 30 and 50. The most prevalent dermoscopic pattern was the globular one. An older parenting age was correlated with an autonomous reason for referral and a later first visit. Our data agreed with previous suggestions demonstrating a strong influence of latitude, sun exposure and ethnic background in the development of the number of nevi. To our knowledge, this is the first study, which evaluated the reasons for dermatological examination and the role of older parents' populations in the decision to refer to a dermatological consultant.

Identifiants

pubmed: 32451385
doi: 10.1038/s41598-020-65690-x
pii: 10.1038/s41598-020-65690-x
pmc: PMC7248059
doi:

Types de publication

Journal Article Observational Study

Langues

eng

Sous-ensembles de citation

IM

Pagination

8594

Références

Downard, C. D., Rapkin, L. B. & Gow, K. W. Melanoma in children and adolescents. Surg. Oncol. 16, 215–220 (2007).
doi: 10.1016/j.suronc.2007.09.006
Wong, J. R., Harris, J. K., Rodriguez-Galindo, C. & Johnson, K. J. Incidence of childhood and adolescent melanoma in the United States: 1973-2009. Pediatrics 131, 846–854 (2013).
doi: 10.1542/peds.2012-2520
Hoang, M. T. & Eichenfield, L. F. The rising incidence of melanoma in children and adolescents. Dermatol. Nurs. 12(188–189), 192–193 (2000).
Wachsmuth, R. C. et al. Heritability and gene-environment interactions for melanocytic nevus density examined in a U.K. adolescent twin study. J. Invest. Dermatol. 117, 348–352 (2001).
doi: 10.1046/j.0022-202x.2001.01415.x
Zhu, G. et al. A major quantitative-trait locus for mole density is linked to the familial melanoma gene CDKN2A: a maximum-likelihood combined linkage and association analysis in twins and their sibs. Am. J. Hum. Genet. 65, 483–492 (1999).
doi: 10.1086/302494
Swerdlow, A. J. et al. Benign melanocytic naevi as a risk factor for malignant melanoma. Br. Med. J. 292, 1555–1559 (1986).
doi: 10.1136/bmj.292.6535.1555
Grob, J. J. et al. Count of benign melanocytic nevi as a major indicator of risk for nonfamilial nodular and superficial spreading melanoma. Cancer 66, 387–395 (1990).
doi: 10.1002/1097-0142(19900715)66:2<387::AID-CNCR2820660232>3.0.CO;2-J
Carli, P., Biggeri, A. & Giannotti, B. Malignant melanoma in Italy: risks associated with common and clinically atypical melanocytic nevi. J. Am. Acad. Dermatol. 32, 734–739 (1995).
doi: 10.1016/0190-9622(95)91451-X
Mitkov, M. et al. Pediatric melanomas often mimic benign skin lesions: A retrospective study. J. Am. Acad. Dermatol. 75(706–711), e4 (2016).
Paradela, S. et al. Prognostic factors for melanoma in children and adolescents: a clinicopathologic, single-center study of 137 Patients. Cancer 116, 4334–4344 (2010).
doi: 10.1002/cncr.25222
Youl, P. et al. Melanoma in adolescents: a case-control study of risk factors in Queensland, Australia. Int. J. Cancer 98, 92–98 (2002).
doi: 10.1002/ijc.10117
English, D. R. & Armstrong, B. K. Melanocytic nevi in children. I. Anatomic sites and demographic and host factors. Am. J. Epidemiol. 139, 390–401 (1994).
doi: 10.1093/oxfordjournals.aje.a117011
Harrison, S. L., MacLennan, R., Speare, R. & Wronski, I. Sun exposure and melanocytic naevi in young Australian children. Lancet 344, 1529–1532 (1994).
doi: 10.1016/S0140-6736(94)90348-4
Gallagher, R. P. et al. Suntan, sunburn, and pigmentation factors and the frequency of acquired melanocytic nevi in children. Similarities to melanoma: the Vancouver Mole Study. Arch. Dermatol. 126, 770–776 (1990).
doi: 10.1001/archderm.1990.01670300070010
MacKie, R. M., English, J., Aitchison, T. C., Fitzsimons, C. P. & Wilson, P. The number and distribution of benign pigmented moles (melanocytic naevi) in a healthy British population. Br. J. Dermatol. 113, 167–174 (1985).
doi: 10.1111/j.1365-2133.1985.tb02060.x
Enta, T. & Kwan, T. Y. Melanocytic nevi in sun-protected Canadian Hutterite children. Arch. Dermatol. 134, 379–381 (1998).
doi: 10.1001/archderm.134.3.379
Rokuhara, S. et al. Number of acquired melanocytic nevi in patients with melanoma and control subjects in Japan: Nevus count is a significant risk factor for nonacral melanoma but not for acral melanoma. J. Am. Acad. Dermatol. 50, 695–700 (2004).
doi: 10.1016/j.jaad.2003.11.053
Dogan, G. Melanocytic nevi in 2783 children and adolescents in Turkey. Pediatr. Dermatol. 24, 489–494 (2007).
doi: 10.1111/j.1525-1470.2007.00500.x
Sigg, C. & Pelloni, F. Frequency of acquired melanonevocytic nevi and their relationship to skin complexion in 939 schoolchildren. Dermatologica 179, 123–128 (1989).
doi: 10.1159/000248337
Colonna, S. & Zina, G. [Acquired melanocytic nevus. Epidemiol. Clin. study a healthy population]. G. Ital. Dermatol. Venereol. 125, 231–236 (1990).
Whiteman, D. C. et al. A comparison of the anatomic distribution of cutaneous melanoma in two populations with different levels of sunlight: the west of Scotland and Queensland, Australia 1982-2001. Cancer Causes Control. 18, 485–491 (2007).
doi: 10.1007/s10552-007-0123-1
Aitken, J. F. et al. Generational shift in melanoma incidence and mortality in Queensland, Australia, 1995-2014. Int. J. Cancer 142, 1528–1535 (2018).
doi: 10.1002/ijc.31141
Printz, C. Sun behaviors and genes may affect future melanoma risk. Cancer 121, 1157 (2015).
pubmed: 25855333
Katalinic, A., Kunze, U. & Schäfer, T. Epidemiology of cutaneous melanoma and non-melanoma skin cancer in Schleswig-Holstein, Germany: incidence, clinical subtypes, tumour stages and localization (epidemiology of skin cancer). Br. J. Dermatol. 149, 1200–1206 (2003).
doi: 10.1111/j.1365-2133.2003.05554.x
Zalaudek, I. et al. Age-related prevalence of dermoscopy patterns in acquired melanocytic naevi. Br. J. Dermatol. 154, 299–304 (2006).
doi: 10.1111/j.1365-2133.2005.06973.x
Worret, W. I. & Burgdorf, W. H. Which direction do nevus cells move? Abtropfung reexamined. Am. J. Dermatopathol. 20, 135–139 (1998).
doi: 10.1097/00000372-199804000-00005
Cramer, S. F. The histogenesis of acquired melanocytic nevi. Based a N. concept. melanocytic differentiation. Am. J. Dermatopathol. 6(Suppl), 289–298 (1984).
Oliveria, S. A. et al. The Framingham school nevus study: a pilot study. Arch. Dermatol. 140, 545–551 (2004).
pubmed: 15148098

Auteurs

Caterina Lanna (C)

Dermatologic Unit, University of Rome Tor Vergata, Roma, Italy. caterinalanna.cl@gmail.com.

Chiara Tartaglia (C)

Dermatologic Unit, University of Rome Tor Vergata, Roma, Italy.

Raffaele Dante Caposiena Caro (RD)

Dermatologic Unit, University of Rome Tor Vergata, Roma, Italy.

Sara Mazzilli (S)

Dermatologic Unit, University of Rome Tor Vergata, Roma, Italy.

Alessandra Ventura (A)

Dermatologic Unit, University of L'Aquila, L'Aquila, Italy.

Luca Bianchi (L)

Dermatologic Unit, University of Rome Tor Vergata, Roma, Italy.

Elena Campione (E)

Dermatologic Unit, University of Rome Tor Vergata, Roma, Italy.

Laura Diluvio (L)

Dermatologic Unit, University of Rome Tor Vergata, Roma, Italy.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH